ATE162310T1 - Nachweis von heparinbindenden seminalproteinen - Google Patents

Nachweis von heparinbindenden seminalproteinen

Info

Publication number
ATE162310T1
ATE162310T1 AT90308341T AT90308341T ATE162310T1 AT E162310 T1 ATE162310 T1 AT E162310T1 AT 90308341 T AT90308341 T AT 90308341T AT 90308341 T AT90308341 T AT 90308341T AT E162310 T1 ATE162310 T1 AT E162310T1
Authority
AT
Austria
Prior art keywords
heparin
binding
detection
seminal
proteins
Prior art date
Application number
AT90308341T
Other languages
English (en)
Inventor
Roy L Ax
David J Miller
Martin A Winer
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE162310T1 publication Critical patent/ATE162310T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/906—Fertility tests
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90308341T 1989-07-28 1990-07-30 Nachweis von heparinbindenden seminalproteinen ATE162310T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38695489A 1989-07-28 1989-07-28

Publications (1)

Publication Number Publication Date
ATE162310T1 true ATE162310T1 (de) 1998-01-15

Family

ID=23527796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90308341T ATE162310T1 (de) 1989-07-28 1990-07-30 Nachweis von heparinbindenden seminalproteinen

Country Status (4)

Country Link
US (1) US5434139A (de)
EP (1) EP0410816B1 (de)
AT (1) ATE162310T1 (de)
DE (1) DE69031928T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346990A (en) * 1987-04-08 1994-09-13 Cytogam, Inc. Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex
US5962241A (en) * 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
CA2143053A1 (en) * 1994-03-14 1995-09-15 Jorge G. Tezon Induction of the acrosome reaction to evaluate the fertilization capability of mammalian sperm
US20050049401A1 (en) * 2003-08-29 2005-03-03 The Arizona Board Of Regents... Fertility prediction of mammalian males and polyclonal antibodies for the prediction thereof
DE102005028453A1 (de) * 2005-06-17 2006-12-28 Philipps-Universität Marburg Verfahren zur Bestimmung und Beeinflussung der Fertilität männlicher Säugetiere und des Menschen
US20070049739A1 (en) * 2005-08-30 2007-03-01 Biomet Manufacturing Corp. Method and system for extracting blood-derived growth factors
EP2364218B1 (de) * 2008-10-31 2020-04-15 Biomerieux, Inc Behälter zur isolierung und identifikation von mikroorganismen
JP6182574B2 (ja) 2008-10-31 2017-08-16 ビオメリュー・インコーポレイテッド 分光法を使用した微生物の分離、キャラクタリゼーションおよび/または同定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
IT1197670B (it) * 1983-06-29 1988-12-06 Serono Ist Farm Frazione antigenica seminale purificata,procedimento per la sua preparazione ed impiego della stessta per il dosaggio degli anticorpi spermioagglutinanti
US4767703A (en) * 1984-04-03 1988-08-30 Wisconsin Alumni Research Foundation Method for assessing the fertility of male mammals

Also Published As

Publication number Publication date
DE69031928D1 (de) 1998-02-19
EP0410816A2 (de) 1991-01-30
DE69031928T2 (de) 1998-05-20
EP0410816A3 (en) 1992-10-07
US5434139A (en) 1995-07-18
EP0410816B1 (de) 1998-01-14

Similar Documents

Publication Publication Date Title
DK339883A (da) Krystallinske silicoaluminophosphater, fremgangsmaade til fremstilling samt anvendelse heraf
ES2101077T5 (es) Procedimiento para la inactivacion de priones.
DK0620854T3 (da) Ekspression og oprensning af rekombinant opløselig vævsfaktor
AU1130392A (en) Synthetic htlv-iii peptides, compositions and uses thereof
NZ319786A (en) HCV NS3 protein fragments with helicase activity and improved solubility
FR2594846B1 (fr) Procede de preparation de la serum albumine humaine mature
ES2115756T3 (es) Derivados de acido sulfonico utilizados en el tratamiento de enfermedades virales.
DE69031928D1 (de) Nachweis von heparinbindenden Seminalproteinen
ATE355375T1 (de) Bakterioferritin aus helicobacter pylori
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DE68912462D1 (de) Xanthenfarbstoffe.
ATE5314T1 (de) Pharmakologisch aktive peptide und deren zusammensetzungen.
BR8600260A (pt) Processo para a preparacao de triacetoxissilanas a partir de tris(amino)silanas
ES2085329T3 (es) Agente anticanceroso proteico.
ES2081797T3 (es) Aminoacidos y derivados peptidicos de 1,4-bis((aminoalquil e hidroxiaminoalquil)amino)-5,8-dihidroxiantraquinonas.
NO944846L (no) Fremgangsmåte for fremstilling av protein C
ATE91304T1 (de) Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
ES2165358T3 (es) Utilizaciones de la proteinquinasa de neurofilamento/tau pk40.
IL95134A0 (en) Method for inhibiting virus replication in mammalian cells using pokeweed antiviralprotein-monoclonal antibody conjugates
IT1184157B (it) Metodo di illuminazione di ambienti in genere in particolare di ambienti di lavoro cosiddetti a spazio aperto
EP0285361A3 (de) Reinigung von Apase-1 und Wiedererlangung des Nematodenresistenzgens
DK628188A (da) Protein og fremgangsmaade til fremstilling deraf
ATE110853T1 (de) Immuntestverfahren für zelluläres eiweiss.
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties